Uncategorized Archives - Page 207 of 248

MondayFeb 26, 2018 9:42 am

SinglePoint, Inc. (SING) Details OTCQB Uplisting, New Board Appointment

Recent uplisting to the OTCQB Venture Market improves company profile New board appointment of Mr. Venugopal Aravamudan, with over 25 years of experience in technology development with major companies SinglePoint will leverage this experience to expand its reach into global markets On February 14, 2018, SinglePoint, Inc. (OTCQB: SING) released an update for shareholders regarding its recent uplisting to the OTCQB Venture Market (http://cnw.fm/w8eUZ). With a market cap of just over $65 million, the company is currently busy completing its 2017 audit for the imminent reporting of its financial results. SinglePoint places great importance on becoming fully reporting so as…

FridayFeb 23, 2018 12:49 pm

Earth Science Tech, Inc.’s (ETST) European Industrial Hemp and Mr. Checkout Could be Key Players in 2018

ETST projects a breakout year in 2018 from its new line of High Grade Full Spectrum Cannabinoids, marketed as a cannabinoid complex Checkout sells to major retailers, such as Walmart and Target, as well as a network of independent distributors and retail owners ETST’s new line is sourced from European industrial hemp, but it is mixed, bottled and packaged in the U.S. Earth Science Tech, Inc. (OTC: ETST) is projecting a breakout year in 2018, resetting its executive team and implementing a new marketing strategy. Playing key roles in the predictions of higher volume and performance are new Netherlands-sourced industrial…

FridayFeb 23, 2018 12:15 pm

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) “Seed to Derivatives” – Vertical Integration in Burgeoning Cannabis Market

Letter of Intent to acquire Agro-Biotech, to become vertically integrated from “seed to derivatives” Development and commercialization of therapeutic pharmaceuticals and nutraceuticals Patented formulation and delivery technologies Scientific studies have provided empirical credence to the medical efficacy of cannabinoids for multiple maladies. Globally, researchers and biopharmaceutical companies are now laser focused on cannabinoid-based therapeutics that may hold blockbuster medical potential, providing solutions to a range of unmet medical needs. However, current drug delivery techniques remain antiquated. There are inherent metabolic and bioavailability issues affecting the consistent, effective delivery of cannabinoids. It’s becoming clear that these new pharmaceutical therapeutics require revolutionary…

ThursdayFeb 22, 2018 4:12 pm

The Green Organic Dutchman’s Strategy Ensures Sustainable Future Growth

The Green Organic Dutchman raised $112 million to fund 970,000 square foot expansion of cannabis cultivation facilities in 2018 This includes $55 million investment by Aurora Cannabis Inc. Strategy positions The Green Organic Dutchman to be one of the world’s largest, most technically advanced cannabis producers Headquartered in Hamilton, Ontario, The Green Organic Dutchman Holdings Ltd., known as “TGOD”, has formed strategic alliances with industry leaders with a view to becoming the world’s largest organic cannabis company. To achieve this goal, the company has taken an approach unique in the cannabis industry, by growing cannabis organically at a low cost,…

ThursdayFeb 22, 2018 2:54 pm

ChineseInvestors.com, Inc. (CIIX) Pursuing a Diversified Future in Cryptocurrency, Baijiu and Cannabis

Chinese investors seek cryptocurrency education as they adapt and continue to diversify portfolios with bitcoin CBD Biotechnology advancing distribution of baijiu CIIX planning to spin-off ChineseHempOil.com and CBD Biotechnology subsidiaries in order to focus on cryptocurrency markets ChineseInvestors.com (OTCQB: CIIX) is an emerging leader in the adoption of cryptocurrencies and blockchain technologies. The company has been leading the way in providing financial information and education for Chinese-speaking investors in the United States and China since 1999. CEO Warren Wang believes that cryptocurrency and blockchain technologies will play a growing role in China’s future economy. Currently, CIIX broadcasts a daily newscast…

ThursdayFeb 22, 2018 12:34 pm

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Sol-Gel Nose-to-Brain Delivery System of Cannabinoids

Universally-patient friendly, meaning formulations that can be used in children and adults alike Transport of drugs through blood-brain barrier marks top priority for researchers North American legal cannabis market projected at more than $24 billion by 2021 Global market for pain management, drugs and devices estimated at over $61 billion by 2023 PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is a Vancouver-based health sciences company dedicated to research and development of innovative, organic and Nature Identical™ options for preventive and curative therapies for a wide array of devastating medical conditions. Developing what the company believes will be the…

WednesdayFeb 21, 2018 2:40 pm

Skinvisible, Inc. (SKVI) Aims to Increase Shareholder Value through Proposed Deal with Quoin

Drug delivery platform ideal for M&A-driven growth $80 billion global dermatology market $30 billion global over-the-counter skincare market Half of the 100 million surgeries performed in the U.S. require post-surgical pain medication, according to Transparency Market Research report If history repeats itself, as we are often told, then Skinvisible, Inc.’s (OTCQB: SKVI) proposed deal with Quoin Pharmaceuticals Limited ("Quoin") could increase shareholder value after execution. In late 2017, the company announced its plan to merge with Quoin, a marriage made in heaven that combines Skinvisible’s virtues as a drug delivery developer with Quoin’s position as a producer of post-surgical pain…

WednesdayFeb 21, 2018 2:01 pm

Pressure BioSciences Inc. (PBIO) Agreement with ISS, Inc. Shows Potential to Enhance Drug Discovery and Development

The two companies entered co-marketing and distribution agreement to be implemented worldwide Pressure BioSciences’ high pressure generator technology can improve optical spectroscopy accuracy and data collection with potentially far-reaching impact on drug development The joint technology will be promoted to scientists all over the world and is expected to generate increased sales starting this year A leading developer and provider of innovative high pressure-based solutions to the global life sciences industry, Pressure BioSciences, Inc. (OTCQB: PBIO) has entered a two-year agreement with ISS, Inc., a prominent designer and manufacturer of advanced scientific instruments with more than 30 years of experience…

WednesdayFeb 21, 2018 11:47 am

Medical Cannabis Payment Solutions (REFG) Helps Fill State Coffers

States that legalize medical cannabis reaping large tax windfalls State-sanctioned cannabis businesses forced into cash-only operation due to federal banking impasse REFG resolves cannabis banking and operational issues, generating more state tax revenues Current regulatory anxiety surrounding cannabis will have little impact on the long-term growth of the industry. Evermore states continue to relax marijuana strictures not only in response to citizen demand but also to generate tax revenues. There’s overwhelming scientific evidence validating the medical efficacy of certain cannabinoids, and states that have legalized marijuana in various forms are finding that cannabis cash is filling state coffers. In 2016,…

TuesdayFeb 20, 2018 4:13 pm

EVIO, Inc. (EVIO) Strengthens Position as Leading Research and Testing Provider for Cannabis Industry

EVIO is the leading accredited provider of analytical services for the cannabis industry Increase in year-on-year revenue of 438 percent from 2016 to 2017 Financing of almost $6 million will fund expansion from nine to 18 labs by the end of 2018 In January 2018, life sciences company and leading provider of accredited cannabis analysis and consulting services EVIO, Inc. (OTCQB: EVIO) announced its financial results for the fiscal year ended September 30, 2017. The company generated approximately $3 million in revenue, representing a year-on-year increase of an impressive 438 percent. Currently, EVIO has nine laboratories located in five states,…